Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, Yesterday
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.

Genetically defined warfarin sensitivity confirmed in study

Jairia Dela Cruz
11 Aug 2017

Genetic polymorphisms in CYP2C9 and VKORC1 affect the pharmacology and safety of warfarin, and patients with venous thromboembolism (VTE) who carry the said polymorphisms spend more time overanticoagulated, require a lower drug dose and are at increased bleeding risk with the drug, according to a pharmacogenetic subanalysis of the Hokusai VTE trial.

The results of the current analysis extend that of the previous analysis of ENGAGE AF-TIMI 48*—a large study comparing edoxaban with warfarin for the prevention of stroke and systemic embolic events in patients with atrial fibrillation—demonstrating that patients on warfarin who were identified as sensitive or highly sensitive responders, based on CYP2C9 and VKORC1 genotypes, had higher warfarin-associated bleeding rates and spent more time overanticoagulated compared with normal responders. [Lancet 2015;385:2280–7]

In the present investigation using data from Hokusai VTE, a randomized noninferiority trial evaluating the safety and efficacy of edoxaban vs warfarin in VTE patients initially treated with heparin, the authors confirmed that patients with genetically defined warfarin sensitivity had indeed heightened risk of bleeding while receiving anticoagulant treatment with the vitamin K antagonist (VKA). [Heart 2017;doi:10.1136/heartjnl-2016-310901]

The risk of major bleeding was higher by 1.38 fold (95 percent CI, 1.11 to 1.71) among sensitive warfarin responders and by 1.79 fold (1.09 to 2.99) among highly sensitive warfarin responders in comparison with normal responders (p=0.0035 and p=0.0252). The two warfarin-sensitive patient groups also had an early discontinuation of heparin therapy (p<0.001), a decreased final weekly warfarin dose (p<0.001) and spent more time overanticoagulated (p<0.001).

The analysis included 3,956 of 8,292 (47.7 percent) adult patients in Hokusai VTE. Among the 1,978 randomized to warfarin, 63.04 percent were normal responders, 34.12 percent were sensitive responders and 2.84 percent were highly sensitive responders.

Despite the presence of limitations that could restrict the generalizability of the results, the data presented in the current analysis have the potential to influence the practical management of warfarin therapy for the treatment of VTE in patients who are sensitive or highly sensitive responders to the VKA, the authors said.

“Although the Food and Drug Administration recommends dose adjustments for warfarin in patients with warfarin-sensitive genotypes, in clinical practice, CYP2C9 and VKORC1 genotypes are not routinely assessed, and it has never been demonstrated that genotyping can reduce the risk of bleeding,” they pointed out.

Thus, further investigations into the potentially beneficial effects of genotyping prior to prescribing anticoagulation therapy in patients with AF or VTE are warranted, the authors said. “Genotype-informed dosing may be especially beneficial in those patients who are initiating therapy, as an individual’s genetic sensitivity could interact with existing clinical factors to exacerbate overall bleeding risk.”


*Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, Yesterday
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.